Tolerability, pharmacokinetics and effects on urinary glucose excretion of single ascending doses of TS 071 in male Japanese volunteers

Trial Profile

Tolerability, pharmacokinetics and effects on urinary glucose excretion of single ascending doses of TS 071 in male Japanese volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 23 May 2016

At a glance

  • Drugs Luseogliflozin (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors Taisho Pharmaceutical
  • Most Recent Events

    • 18 Feb 2014 Results published in the Advances in Therapy.
    • 04 Jul 2011 New trial record
    • 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top